Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$1.27B |
| 2 |
JPMorgan Chase
JPM
|
+$1.2B |
| 3 |
Microsoft
MSFT
|
+$1.06B |
| 4 |
Wells Fargo
WFC
|
+$1.05B |
| 5 |
Coty
COTY
|
+$772M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$1.3B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 3 |
Roper Technologies
ROP
|
+$1.09B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
NXP Semiconductors
NXPI
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.49% |
| 2 | Technology | 14.92% |
| 3 | Healthcare | 13.4% |
| 4 | Consumer Discretionary | 11.03% |
| 5 | Communication Services | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Revvity
RVTY
$12.8B
| $9.68M | ﹤0.01% |
185,681
-87,636
| -32% | -$4.58M |
|
1927
Sibanye-Stillwater
SBSW
$7.02B
| $9.68M | ﹤0.01% |
1,454,469
-14,109
| -1% | -$129K |
|
1928
Aldeyra Therapeutics
ALDX
$96.5M
| $9.62M | ﹤0.01% |
1,797,811
| – | – |
|
1929
iShares Russell 2000 Value ETF
IWN
$14.6B
| $9.62M | ﹤0.01% |
80,868
+143
| +0.2% | +$15.8K |
|
1930
Carlyle Group
CG
$17.9B
| $9.62M | ﹤0.01% |
630,500
| – | – |
|
|
ESPR
1931
DELISTED
Esperion Therapeutics
ESPR
| $9.59M | ﹤0.01% |
766,009
| – | – |
|
1932
Kinross Gold
KGC
$30.5B
| $9.58M | ﹤0.01% |
3,070,439
-1,873,374
| -38% | -$6.58M |
|
1933
Emergent Biosolutions
EBS
$389M
| $9.47M | ﹤0.01% |
288,348
+81,898
| +40% | +$2.46M |
|
|
HWCC
1934
DELISTED
Houston Wire & Cable Company
HWCC
| $9.46M | ﹤0.01% |
1,456,183
+30,600
| +2% | +$184K |
|
1935
Codexis
CDXS
$156M
| $9.46M | ﹤0.01% |
2,055,916
-77,366
| -4% | -$363K |
|
|
INWK
1936
DELISTED
InnerWorkings, Inc.
INWK
| $9.43M | ﹤0.01% |
957,231
+78,900
| +9% | +$730K |
|
1937
Senseonics Holdings Inc
SENS
$270M
| $9.37M | ﹤0.01% |
175,439
| – | – |
|
|
JONE
1938
DELISTED
Jones Energy, Inc.
JONE
| $9.34M | ﹤0.01% |
101,566
+2,767
| +3% | +$224K |
|
1939
Corbus Pharmaceuticals
CRBP
$177M
| $9.33M | ﹤0.01% |
+36,810
| New | +$8.44M |
|
|
BRS
1940
DELISTED
Bristow Group, Inc.
BRS
| $9.32M | ﹤0.01% |
455,300
+278,500
| +158% | +$4.2M |
|
|
LUMO
1941
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $9.3M | ﹤0.01% |
100,540
+54,704
| +119% | +$6.16M |
|
|
LVNTA
1942
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $9.26M | ﹤0.01% |
251,168
-434,485
| -63% | -$17.1M |
|
|
BT
1943
DELISTED
BT Group plc (ADR)
BT
| $9.21M | ﹤0.01% |
399,758
+54,830
| +16% | +$1.27M |
|
|
CLSD
1944
DELISTED
Clearside Biomedical
CLSD
| $9.21M | ﹤0.01% |
68,640
+54,259
| +377% | +$13.6M |
|
1945
Artivion
AORT
$1.27B
| $9.17M | ﹤0.01% |
479,081
+79,081
| +20% | +$1.44M |
|
1946
Caesars Entertainment
CZR
$6.13B
| $9.16M | ﹤0.01% |
+540,512
| New | +$7.57M |
|
|
NYMTO
1947
DELISTED
New York Mortgage Trust, Inc. 7.875% Series C Cumulative Redeemable Preferred Stock
NYMTO
| $9.16M | ﹤0.01% |
401,558
| – | – |
|
|
MMP
1948
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $9.15M | ﹤0.01% |
120,936
+2,400
| +2% | +$168K |
|
1949
UGI
UGI
$7.62B
| $9.13M | ﹤0.01% |
198,100
-115,184
| -37% | -$5.16M |
|
|
AUY
1950
DELISTED
Yamana Gold, Inc.
AUY
| $9.06M | ﹤0.01% |
3,225,620
-2,957,104
| -48% | -$9.66M |
|
Similar funds
Fidelity Investments's Q4 2016 Portfolio in Review
As of Q4 2016, Fidelity Investments held 2,801 positions worth $748B, down 0.35% from $751B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Fidelity Investments's Q4 2016 filing shows 155 new, 1,033 increased, 1,183 reduced and 156 closed positions. Its largest new stake was Fortis: 9,255,423 shares worth $286M. The largest sale was Medtronic, an estimated $1.3B.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
- Fidelity Investments's largest Q4 2016 buy was Fortis: 9,255,423 shares worth $286M.
- Fidelity Investments added most to Bank of America in Q4 2016, an estimated $1.27B increase.
- Fidelity Investments's biggest Q4 2016 reduction was Medtronic, cutting an estimated $1.3B.
- Fidelity Investments fully exited Amsurg Corp in Q4 2016, selling an estimated $473M.
- Fidelity Investments's ten largest holdings make up 16% of its $748B portfolio in Q4 2016.
- Fidelity Investments opened 155 new positions and closed 156 in Q4 2016.
- Fidelity Investments's portfolio value fell 0.35% quarter-over-quarter to $748B.
Based on Fidelity Investments's 13F filing for Q4 2016, filed 10 Feb 2017.